Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab

Acta Derm Venereol. 2024 Sep 30:104:adv40801. doi: 10.2340/actadv.v104.40801.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antineoplastic Agents, Immunological / adverse effects
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Lupus Erythematosus, Cutaneous* / chemically induced
  • Lupus Erythematosus, Cutaneous* / diagnosis
  • Male
  • Treatment Outcome

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Immune Checkpoint Inhibitors